Contrast-inducible nephropathy in coronarography in patients with type 2 diabetes mellitus: risk factors, prognostic significance, prophylactic approaches

Aim. To determine risk factors, prognostic implications and prophylaxis of contrast-inducible nephropathy (CIN) during coronarography (CG) in patients with type 2 diabetes mellitus (DM). Material and methods. Records for 151 patients with type 2 DM and 50 non-diabetic patients examined with CG in A....

Full description

Bibliographic Details
Main Authors: Minara Shamkhalovna Shamkhalova, Natal'ya Vladislavovna Zaytseva, Kseniya Olegovna Kurumova, Marina Vladimirovna Shestakova, Aleksandr Dmitrievich Deev, Simon Teymurazovich Matskeplishvili, El'vira Faatovna Tugeeva, Yuriy Iosifovich Buziashvili, M Sh Shamkhalova, N V Zaitseva, K O Kurumova, M V Shestakova, A D Deev, S T Matskeplishvili, E F Tugeeva, Yu I Buziashvili
Format: Article
Language:Russian
Published: "Consilium Medicum" Publishing house 2009-08-01
Series:Терапевтический архив
Subjects:
Online Access:https://ter-arkhiv.ru/0040-3660/article/view/30489
id doaj-764c1dc9781e4b8b8b86ed853801518f
record_format Article
spelling doaj-764c1dc9781e4b8b8b86ed853801518f2020-11-25T03:12:26Zrus"Consilium Medicum" Publishing houseТерапевтический архив0040-36602309-53422009-08-01818364227516Contrast-inducible nephropathy in coronarography in patients with type 2 diabetes mellitus: risk factors, prognostic significance, prophylactic approachesMinara Shamkhalovna ShamkhalovaNatal'ya Vladislavovna ZaytsevaKseniya Olegovna KurumovaMarina Vladimirovna ShestakovaAleksandr Dmitrievich DeevSimon Teymurazovich MatskeplishviliEl'vira Faatovna TugeevaYuriy Iosifovich BuziashviliM Sh ShamkhalovaN V ZaitsevaK O KurumovaM V ShestakovaA D DeevS T MatskeplishviliE F TugeevaYu I BuziashviliAim. To determine risk factors, prognostic implications and prophylaxis of contrast-inducible nephropathy (CIN) during coronarography (CG) in patients with type 2 diabetes mellitus (DM). Material and methods. Records for 151 patients with type 2 DM and 50 non-diabetic patients examined with CG in A.N. Bakulev Research Center for Cardiovascular Surgery in 2000-2007 were analysed retrospectively. All the patients have undergone clinical examination including tests for blood serum creatinine before and after 48 hours after CG, standard ECG and echocardiography. Glomerular filtration rate was estimated by MDRD formula. Selective CG was made with application of contrast agent Omnipak-300 (iohexol). Results. CIN after CG more frequently developed in diabetics than in non-diabetic patients matched for age, renal function, dose of contrast medium and hydration regime (40.4 and 16%, respectively; p < 0.002). Risk of CIN in patients with type 2 DM was associated with cardiac failure of NYHA class III-IV, anemia, dose of the contrast agent, intake of diuretic drugs before and after the procedure, multiple affection of the coronary vessels, necessity of intervention. Patients with type 2 DM and CIN showed more rapid decline of the renal function, more frequently developed severe cardiovascular events, had worse 1-year survival. Conclusion. High probability of CIN and its prognostic significance in type 2 DM patients necessitates assessment of an individual risk for taking preventive measures during conduction of contrast diagnostic procedures.https://ter-arkhiv.ru/0040-3660/article/view/30489contrast-inducible nephropathydiabetes mellitusrisk factorsprognostic significanceprophylaxis
collection DOAJ
language Russian
format Article
sources DOAJ
author Minara Shamkhalovna Shamkhalova
Natal'ya Vladislavovna Zaytseva
Kseniya Olegovna Kurumova
Marina Vladimirovna Shestakova
Aleksandr Dmitrievich Deev
Simon Teymurazovich Matskeplishvili
El'vira Faatovna Tugeeva
Yuriy Iosifovich Buziashvili
M Sh Shamkhalova
N V Zaitseva
K O Kurumova
M V Shestakova
A D Deev
S T Matskeplishvili
E F Tugeeva
Yu I Buziashvili
spellingShingle Minara Shamkhalovna Shamkhalova
Natal'ya Vladislavovna Zaytseva
Kseniya Olegovna Kurumova
Marina Vladimirovna Shestakova
Aleksandr Dmitrievich Deev
Simon Teymurazovich Matskeplishvili
El'vira Faatovna Tugeeva
Yuriy Iosifovich Buziashvili
M Sh Shamkhalova
N V Zaitseva
K O Kurumova
M V Shestakova
A D Deev
S T Matskeplishvili
E F Tugeeva
Yu I Buziashvili
Contrast-inducible nephropathy in coronarography in patients with type 2 diabetes mellitus: risk factors, prognostic significance, prophylactic approaches
Терапевтический архив
contrast-inducible nephropathy
diabetes mellitus
risk factors
prognostic significance
prophylaxis
author_facet Minara Shamkhalovna Shamkhalova
Natal'ya Vladislavovna Zaytseva
Kseniya Olegovna Kurumova
Marina Vladimirovna Shestakova
Aleksandr Dmitrievich Deev
Simon Teymurazovich Matskeplishvili
El'vira Faatovna Tugeeva
Yuriy Iosifovich Buziashvili
M Sh Shamkhalova
N V Zaitseva
K O Kurumova
M V Shestakova
A D Deev
S T Matskeplishvili
E F Tugeeva
Yu I Buziashvili
author_sort Minara Shamkhalovna Shamkhalova
title Contrast-inducible nephropathy in coronarography in patients with type 2 diabetes mellitus: risk factors, prognostic significance, prophylactic approaches
title_short Contrast-inducible nephropathy in coronarography in patients with type 2 diabetes mellitus: risk factors, prognostic significance, prophylactic approaches
title_full Contrast-inducible nephropathy in coronarography in patients with type 2 diabetes mellitus: risk factors, prognostic significance, prophylactic approaches
title_fullStr Contrast-inducible nephropathy in coronarography in patients with type 2 diabetes mellitus: risk factors, prognostic significance, prophylactic approaches
title_full_unstemmed Contrast-inducible nephropathy in coronarography in patients with type 2 diabetes mellitus: risk factors, prognostic significance, prophylactic approaches
title_sort contrast-inducible nephropathy in coronarography in patients with type 2 diabetes mellitus: risk factors, prognostic significance, prophylactic approaches
publisher "Consilium Medicum" Publishing house
series Терапевтический архив
issn 0040-3660
2309-5342
publishDate 2009-08-01
description Aim. To determine risk factors, prognostic implications and prophylaxis of contrast-inducible nephropathy (CIN) during coronarography (CG) in patients with type 2 diabetes mellitus (DM). Material and methods. Records for 151 patients with type 2 DM and 50 non-diabetic patients examined with CG in A.N. Bakulev Research Center for Cardiovascular Surgery in 2000-2007 were analysed retrospectively. All the patients have undergone clinical examination including tests for blood serum creatinine before and after 48 hours after CG, standard ECG and echocardiography. Glomerular filtration rate was estimated by MDRD formula. Selective CG was made with application of contrast agent Omnipak-300 (iohexol). Results. CIN after CG more frequently developed in diabetics than in non-diabetic patients matched for age, renal function, dose of contrast medium and hydration regime (40.4 and 16%, respectively; p < 0.002). Risk of CIN in patients with type 2 DM was associated with cardiac failure of NYHA class III-IV, anemia, dose of the contrast agent, intake of diuretic drugs before and after the procedure, multiple affection of the coronary vessels, necessity of intervention. Patients with type 2 DM and CIN showed more rapid decline of the renal function, more frequently developed severe cardiovascular events, had worse 1-year survival. Conclusion. High probability of CIN and its prognostic significance in type 2 DM patients necessitates assessment of an individual risk for taking preventive measures during conduction of contrast diagnostic procedures.
topic contrast-inducible nephropathy
diabetes mellitus
risk factors
prognostic significance
prophylaxis
url https://ter-arkhiv.ru/0040-3660/article/view/30489
work_keys_str_mv AT minarashamkhalovnashamkhalova contrastinduciblenephropathyincoronarographyinpatientswithtype2diabetesmellitusriskfactorsprognosticsignificanceprophylacticapproaches
AT natalyavladislavovnazaytseva contrastinduciblenephropathyincoronarographyinpatientswithtype2diabetesmellitusriskfactorsprognosticsignificanceprophylacticapproaches
AT kseniyaolegovnakurumova contrastinduciblenephropathyincoronarographyinpatientswithtype2diabetesmellitusriskfactorsprognosticsignificanceprophylacticapproaches
AT marinavladimirovnashestakova contrastinduciblenephropathyincoronarographyinpatientswithtype2diabetesmellitusriskfactorsprognosticsignificanceprophylacticapproaches
AT aleksandrdmitrievichdeev contrastinduciblenephropathyincoronarographyinpatientswithtype2diabetesmellitusriskfactorsprognosticsignificanceprophylacticapproaches
AT simonteymurazovichmatskeplishvili contrastinduciblenephropathyincoronarographyinpatientswithtype2diabetesmellitusriskfactorsprognosticsignificanceprophylacticapproaches
AT elvirafaatovnatugeeva contrastinduciblenephropathyincoronarographyinpatientswithtype2diabetesmellitusriskfactorsprognosticsignificanceprophylacticapproaches
AT yuriyiosifovichbuziashvili contrastinduciblenephropathyincoronarographyinpatientswithtype2diabetesmellitusriskfactorsprognosticsignificanceprophylacticapproaches
AT mshshamkhalova contrastinduciblenephropathyincoronarographyinpatientswithtype2diabetesmellitusriskfactorsprognosticsignificanceprophylacticapproaches
AT nvzaitseva contrastinduciblenephropathyincoronarographyinpatientswithtype2diabetesmellitusriskfactorsprognosticsignificanceprophylacticapproaches
AT kokurumova contrastinduciblenephropathyincoronarographyinpatientswithtype2diabetesmellitusriskfactorsprognosticsignificanceprophylacticapproaches
AT mvshestakova contrastinduciblenephropathyincoronarographyinpatientswithtype2diabetesmellitusriskfactorsprognosticsignificanceprophylacticapproaches
AT addeev contrastinduciblenephropathyincoronarographyinpatientswithtype2diabetesmellitusriskfactorsprognosticsignificanceprophylacticapproaches
AT stmatskeplishvili contrastinduciblenephropathyincoronarographyinpatientswithtype2diabetesmellitusriskfactorsprognosticsignificanceprophylacticapproaches
AT eftugeeva contrastinduciblenephropathyincoronarographyinpatientswithtype2diabetesmellitusriskfactorsprognosticsignificanceprophylacticapproaches
AT yuibuziashvili contrastinduciblenephropathyincoronarographyinpatientswithtype2diabetesmellitusriskfactorsprognosticsignificanceprophylacticapproaches
_version_ 1724650362090029056